Integrating Multiple Specialties into Professional Training and Practice: A Vascular Surgeon’s Perspective John J. Ricotta MD FACS Harold Hawfield Chair.

Slides:



Advertisements
Similar presentations
UDETMA Mission: Reduce the incidence of cardiovascular disease Methodology of UDETMA: Use of noninvasive tests (carotid ultrasound, ankle-brachial index)
Advertisements

Peripheral Arterial Disease Mehul Bhatt, MD Interventional Cardiology / Vascular Medicine Athens Heart Center.
THE ACUTE NEED FOR DELIVERY SYSTEM REFORM MARGARET E. OKANE.
Preventing Strokes One at a Time Acute Interventions and Management 2009.
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
St Luke’s- Hospital Carotid Intervention Position Statement1.
HFMA December Attacking Rising Costs 23% of the Medicare population has a chronic condition with 5 or more co-morbid conditions that compel them.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
The Vascular Quality Initiative Using Registries to Provide Clinical Evidence Jack L. Cronenwett, M.D. Medical Director Society for Vascular Surgery Patient.
The role of public health in achieving the “toward zero deaths - TZD” goals AASHTO Safety Leadership Forum V The Paris Hotel, Las Vegas, NV May 5, 2011.
ACHD Patients Should Receive Treatment in Adult Institutions Society of Thoracic Surgeons Adult Cardiac Surgery Database reports 39,872 adults undergoing.
Specialist Physical & Mental Health Private Rehabilitation Services.
New York City Health and Hospitals Corporation: Providing Health Care Quality and Value for New York City Residents Anne-Marie J. Audet, MD, MSc, FACP.
Linda D Urden, DNSc, RN, CNS, NE-BC, FAAN Professor and Director Master’s and International Nursing Programs Hahn School of Nursing and Health Science.
Drivers of Healthcare Analytics
Interventional Radiology in Greece Elias N Brountzos, EBIR Head IR Division Attikon University Hospital 2 nd Dept of Radiology, School of Medicine National.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
What Is Peripheral Vascular Disease? Daniel B. Walsh, M.D. Professor of Surgery, Section of Vascular Surgery Vice-Chair, Department of Sugery Dartmouth-Hitchcock.
Management of Type 2 Diabetes New Zealand Guidelines Group.
0 IRIS A Qualified Clinical Data Registry Consumer-Purchaser Alliance September 9, 2014.
AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Linking Together to.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
The Asheville Project “Asheville”.
MidAtlantic Vascular, LLC Critical Limb Ischemia. P.A.D. Detection, Treatment, and Referral Paul Sasser MD FACS.
ACC/AHA 2006 guidelines on the management of PAD.
Accountable Care Organizations: Health Care Delivery Redesign Thomas J. Biuso MD, MBA UnitedHealthcare Medical Director Clinical Assistant Professor of.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Blood Pressure Control 13th Annual Meeting - National Forum for Heart Disease and Stroke Prevention October 21, 2015 Cindy Ferrara, RN, MS Essentia Health.
Medical Management of Claudication: Just Walk it Off!!
Maj. Gen. Mohammad A. Aldayel, MD MBBS, MSc, ABFM Monday 05 October,2015.
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
What is good health? How would you describe good health for yourself? How would you describe good health for those you love? How would you describe a good.
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Vascular and Endovascular Surgery
Management of Hypertension according to JNC 7
ANA Definition of Nursing
Improved Wound Management At Lower Cost: A Sensible Goal For Australia
CRT 2012 Venous Disease.
Anticoagulation after peripheral Vascular Intervention
John. J Ricotta, MD, FACS Professor of Surgery, Georgetown University
Carotid Artery Stenosis
Critical Appraisal of the European CAS Trials
Spinal Cord Ischemia during TEVAR
Antithrombotic Therapy in Peripheral Artery Disease
Crossing SFA-Popliteal Artery CTO’s
2017 Annual Data Report Healthy People 2020.
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Andre Lamy on behalf of the COMPASS Investigators
Diabetes Health Status Report
2018 Annual Data Report Volume 3: Healthy People 2020
Factor Xa Inhibitors in PAD
Community Collaboration A Community Promotora Model
CanMEDS Roles Covered X
Health and Social Services in the Department of Health
Integrating Evidence into RT Practice: An Important Focus for the Profession Chapter 15 HPR 453.
The Research Question Background: Question:
Annual Quality Framework
CanMEDS Roles Covered X
Surgical Champion Tool Kit
Vascular Surgery Michael Ricci, MD.
Limb Preservation Center:The New Frontier
From Theory to Practice: Creating a limb Preservation Center
Office Or Outpatient Centers Are The Best Place To Perform Most Arterial And Venous Interventional Treatments: Precautions And Current Status Of Their.
Influence of Hospital Volume on Outcomes of Thoracic Endovascular Repair in Vascular Quality Initiative Database: 5-year National Study. Presenting Author:
Impact of quality on day-to-day efforts of PHC
Konstantinos Katsanos Joseph Mills Sigrid Nikol Jim Reekers
CanMEDS Roles Covered X
Presentation transcript:

Integrating Multiple Specialties into Professional Training and Practice: A Vascular Surgeon’s Perspective John J. Ricotta MD FACS Harold Hawfield Chair of Surgery Washington Hospital Center

John J. Ricotta, MD DISCLOSURES I have no real or apparent conflicts of interest to report.

Vascular Disease: A Distinct Specialty 90 M Hypertensives / 23 M Diabetics 133,000 amputations annually 750,000 strokes annually 2.5% males over 50 have AAA 5% US adult population with “PAD” 10-30% adults have venous disease 4% of >65 have CVI with Ulcers

Vascular Disease: Poorly Taught, Poorly Practiced Dx and Mgmt of Vascular Diseases not a major focus of Core Residencies Most patients with PVD do not have recommended medical treatment Antiplatelet agents Statins ACE’s & ARB’s Smoking cessation Prevention / Rehab Programs are lacking

Vascular Disease: Too Many Interventions? > 80% of > 170,000 annual carotid interventions are for asymptomatic disease Impact of SFA intervention on life and limb is marginal No demonstrated benefit of intervention for AAA<5.5 cm, TAA <6 cm. Minimal benefit of Renal PTA

Vascular Disease: Need to Refocus Procedure / Intervention oriented Identify and treat asymptomatic or moderately symptomatic disease Prevention and Medical Management need improvement WHAT WILL HAPPEN IF (WHEN) THE INCENTIVES CHANGE?

Vascular Disease: The Future? Disease rather than procedure oriented Reward comprehensive management rather than episodes of care “VASCULAR HOME” Outcome driven Risk Adjusted Independently Audited

The Future Vascular Practitioner: A Vascular Surgeon’s Perspective Broad Knowledge of Vascular Disease Expertise in Vascular Imaging Evidence based Subspecialization – Intervention and Non Intervention Capable of Open and Endoluminal Interventions – reduce selection bias Regionalization for High end interventions?

Unified Model of Training

“Funnel” Model of Training

Current and Future Training Models in Vascular Surgery “5 + 2” – 2 years Vascular after 5 years GS “0 +5” – 24 months “Core” plus 36 months Vascular 60 months of clinical training 36 months dedicated to Vascular Care “0+7” – 24 months Core, 36 months Vascular , 24 months Thoracic

Essentials of a Common Training Pathway: Vascular Perspective 5 years of clinical training 3 years Vascular Training Interventionalists train in Open and Endovascular Techniques. Non Interventionalists focus on VM, VL, Venous Disease Certification through multiple Boards?

Integrating Specialties into Current Practice Much more difficult in current climate Different indications for intervention Lack of Common Outcome Reporting “Cherry picking” cases Lack of Financial Integration Money and Ego

Guidelines for Integration Common Practice Standards evidence based when possible different approaches require entry into a common database Transparent Outcomes Reporting Independent Audit Common Quality Review Commitment to comprehensive patient care – individual or practice group

Goals of Vascular Practice Integration: Disease rather than procedure oriented Provide comprehensive management rather than episodes of care “VASCULAR HOME” Outcome driven Risk Adjusted Independently Audited